Department of Radiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8827.
Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX.
AJR Am J Roentgenol. 2020 Apr;214(4):908-916. doi: 10.2214/AJR.19.21604. Epub 2020 Feb 18.
The purpose of this study is to evaluate the prognostic value of quantitative metabolic parameters from pretreatment PET/CT scans of patients with squamous cell cervical cancer. This retrospective study included 120 patients with biopsy-proven squamous cell carcinoma of the cervix who underwent FDG PET/CT for initial tumor staging. The primary tumor maximum standardized uptake value (SUV) and mean standardized uptake value (SUV), tumor glycolytic activity, metabolic tumor volume (MTV), and metabolic intratumoral heterogeneity index (calculated as the AUC for the cumulative standardized uptake value [SUV]-volume histogram [CSH] index) were obtained. Information on patient demographic characteristics and tumor staging were collected. Median follow-up was 27.5 months. Overall survival (OS) and progression-free survival (PFS) were calculated using a multivariate Cox proportional hazards regression model and log-rank (Mantel-Cox) test to generate Kaplan-Meier survival plots. The mean (± SD) age of the patients was 54.4 ± 13.1 years. Twenty-two patients had stage I disease; 58, stage II; 23, stage III; and 17, stage IV. Thirty-three patients died, 82 were living, and five were lost to follow-up and were censored; 29 patients had disease progression. The median survival was 74.9 months (95% CI, 63.6-86.9 months). A higher MTV was significantly associated with reduced OS in multivariate analysis (hazard ratio, 1.085; 95% CI, 1.036-1.136; = 0.0005). A higher AUC-CSH index (denoting lower tumor heterogeneity) was significantly associated with increased OS (hazard ratio, 0.662; 95% CI, 0.448-0.979; = 0.04) and PFS (hazard ratio, 0.683; 95% CI, 0.471-0.991; = 0.045) in multivariate analysis. Kaplan-Meier survival analysis using the median value for MTV (61 mL) significantly predicted OS ( = 0.0009). Tumor heterogeneity on pretreatment PET/CT is associated with OS and PFS in patients with cervical cancer. MTV is significantly associated with OS.
本研究旨在评估经氟代脱氧葡萄糖正电子发射断层扫描(FDG PET/CT)检查的鳞状细胞宫颈癌患者的定量代谢参数对预后的评估价值。本回顾性研究纳入了 120 例经活检证实的宫颈癌患者,这些患者均接受 FDG PET/CT 进行初始肿瘤分期。获取原发肿瘤最大标准摄取值(SUV)和平均标准摄取值(SUV)、肿瘤糖酵解活性、代谢肿瘤体积(MTV)和肿瘤内代谢异质性指数(通过计算累积 SUV-体积直方图 [CSH] 指数的 AUC 计算得出)。收集患者人口统计学特征和肿瘤分期信息。中位随访时间为 27.5 个月。使用多变量 Cox 比例风险回归模型和对数秩(Mantel-Cox)检验计算总生存(OS)和无进展生存(PFS),生成 Kaplan-Meier 生存图。患者的平均(± SD)年龄为 54.4 ± 13.1 岁。22 例患者为Ⅰ期疾病,58 例为Ⅱ期,23 例为Ⅲ期,17 例为Ⅳ期。33 例患者死亡,82 例患者存活,5 例患者失访并被删失,29 例患者疾病进展。中位生存期为 74.9 个月(95%CI,63.6-86.9 个月)。多变量分析显示,较高的 MTV 与 OS 降低显著相关(风险比,1.085;95%CI,1.036-1.136; = 0.0005)。较高的 AUC-CSH 指数(表示肿瘤异质性较低)与 OS 增加显著相关(风险比,0.662;95%CI,0.448-0.979; = 0.04)和 PFS 增加显著相关(风险比,0.683;95%CI,0.471-0.991; = 0.045)。使用 MTV 中位数(61 mL)进行的 Kaplan-Meier 生存分析显著预测了 OS( = 0.0009)。在宫颈癌患者中,肿瘤预处理 PET/CT 的异质性与 OS 和 PFS 相关。MTV 与 OS 显著相关。